Edition:
India

Atossa Genetics Inc (ATOS.OQ)

ATOS.OQ on NASDAQ Stock Exchange Capital Market

2.48USD
1:30am IST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.48
Open
$2.59
Day's High
$2.64
Day's Low
$2.46
Volume
30,725
Avg. Vol
47,860
52-wk High
$18.96
52-wk Low
$2.03

Latest Key Developments (Source: Significant Developments)

Atossa Genetics Receives Positive Interim Review From Independent Safety Committee In Phase 1 Topical Endoxifen Dose Escalation Study In Men
Tuesday, 24 Apr 2018 

April 24 (Reuters) - Atossa Genetics Inc ::ATOSSA GENETICS RECEIVES POSITIVE INTERIM REVIEW FROM INDEPENDENT SAFETY COMMITTEE IN PHASE 1 TOPICAL ENDOXIFEN DOSE ESCALATION STUDY IN MEN.ATOSSA GENETICS - INDEPENDENT SAFETY COMMITTEE REVIEWED BLINDED DATA FROM FIRST GROUP IN STUDY, CONCLUDED STUDY MAY ADVANCE TO NEXT DOSING LEVEL.  Full Article

Atossa Genetics posts Q3 loss per share ‍$0.18​
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Atossa Genetics Inc :Atossa Genetics announces third quarter 2017 financial results and provides company update.Atossa Genetics Inc qtrly loss per share ‍$0.18​.  Full Article

L1 Capital Global Opportunities Master Fund reports 9.01 pct passive stake in ‍atossa Genetics, as of Oct. 26
Saturday, 4 Nov 2017 

Nov 3 (Reuters) - L1 Capital Global Opportunities Master Fund Ltd: :L1 capital global opportunities master fund ltd reports 9.01% passive stake in ‍atossa genetics inc, as of october 26, 2017 - SEC filing‍​.  Full Article

Empery Asset Management reports 9.01 pct passive stake in Atossa Genetics
Wednesday, 1 Nov 2017 

Oct 31 (Reuters) - Empery Asset Management LP::Empery Asset Management LP reports 9.01 percent passive stake in Atossa Genetics as of Oct 26 - SEC filing‍​.  Full Article

Atossa Genetics announces pricing of $5.1 million public offering
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Atossa Genetics Inc :Atossa Genetics announces pricing of $5.1 million public offering of common stock.Says public offering of 11.5 million common shares priced at $0.44per share.  Full Article

Atossa Genetics announces proposed public offering of common stock
Thursday, 26 Oct 2017 

Oct 25 (Reuters) - Atossa Genetics Inc ::Atossa Genetics announces proposed public offering of common stock.Says ‍intends to offer and sell shares of its common stock in an underwritten public offering​.  Full Article

Atossa Genetics announces preliminary results from Phase 1 study of topical Endoxifen
Thursday, 14 Sep 2017 

Sept 14 (Reuters) - Atossa Genetics Inc ::Atossa Genetics announces preliminary results from Phase 1 study of topical Endoxifen.Atossa Genetics Inc says expects to announce results from oral arm of Phase 1 study in next 30-60 days.Atossa Genetics Inc says ‍all objectives were successfully met in trial​.Atossa Genetics says‍ no clinically significant safety signals,no clinically significant adverse events in participants receiving topical Endoxifen​.  Full Article

Atossa Genetics qtrly loss per share $0.45
Friday, 12 May 2017 

May 11 (Reuters) - Atossa Genetics Inc ::Atossa Genetics announces first quarter 2017 financial results and provides company update.Qtrly loss per share $0.45.  Full Article

Atossa prices underwritten public offering of 1,150,000 common shares
Wednesday, 31 Aug 2016 

Atossa Genetics Inc : Atossa genetics, inc. Prices underwritten public offering of 1,150,000 common shares .Says public offering of 1.15 million common shares priced at $2.50per share.  Full Article

Atossa Genetics announces proposed public offering of common stock
Wednesday, 31 Aug 2016 

Atossa Genetics Inc : Announces proposed public offering of common stock .Intends to use proceeds for working capital and to fund other general corporate purposes, including funding costs of clinical trials.  Full Article

BRIEF-Intracoastal Capital Reports 5.9 Pct passive Stake In Atossa Genetics Inc, As Of April 23, 2018

* INTRACOASTAL CAPITAL LLC REPORTS 5.9 PERCENT PASSIVE STAKE IN ATOSSA GENETICS INC, AS OF APRIL 23, 2018 - SEC FILING Source text for Eikon: (http://bit.ly/2Ki2uGi) Further company coverage: